GLP-1s
Newsroom
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
• Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible • New offering helps employers meet growing ...
Read More
Article
New Evernorth EnReachRx model expands its suite of GLP-1 solutions, works to improve patient outcomes and drive value
Read More
Article
Podcast: Understanding GLP-1 market challenges and actionable strategies for managing impact
April 22, 2025
Listen to the latest episode of the Health Unscripted Podcast for a deep dive into the challenges and opportunities within the GLP-1 landscape.
Report
Pharmacy in Focus: Navigating GLP-1 cost, demand and sustainability
With demand and utilization expanding, comprehensive clinical support and cost-management strategies are crucial to ensuring accessibility and safeguarding health care budgets.
Read More
Article
Coupling GLP-1 weight loss with mental health support
Learn about the behavioral health considerations that employers should be mindful of when it comes to GLP-1 users.
Read More
Article
Evernorth chief bullish on driving affordability through biosimilars and access through guided care
Read More